Friday, August 19, 2011

Endoscopy Market to Reach $34 Billion by 2016

August 15, 2011 10:08 ET

Endoscopy Market to Reach $34 Billion by 2016


ROCKVILLE, MD--(Marketwire - Aug 15, 2011) - MarketResearch.com has announced the addition of the new report "Endoscopy Devices: Applications and Global Markets" to their collection of Medical Devices market reports. For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=6481743

The overall medical device market is very large; endoscopy is a significant component of that market. For companies with an effective strategy, market opportunity awaits. However, the ability to develop an effective strategy begins where opportunity exists and ends with effective execution and capturing profit from the opportunity.

The endoscopy market is positioned for significant growth in the next 5 years. The endoscopy market worldwide was $23.3 billion in 2010 and is projected to reach nearly $24.8 billion in 2011. This is further anticipated to increase to $33.7 billion by 2016 at a compound annual growth rate (CAGR) of 6.4%.

Laparoscopy accounts for more than 26% of the total market and is expected to reach $6.8 billion by end of 2011 and to increase up to $10.6 billion by 2016 at a compound annual growth rate (CAGR) of 9.2%.

Endoscopy of the GI track for tumors, adhesions, diverticulitis, etc. is projected to experience an increase from $3.7 billion in 2011 to more than $4.9 billion in 2016, a CAGR of 5.7%.

This is due, in part, to new applications for the technology, as well as new innovations in the technology itself. The other major factor that will contribute to this growth is the recognition of this technology in emerging markets like Japan and Vietnam. Continued worldwide growth is expected in other geographic areas due to a growing middle class in countries such as India, China, Brazil, and Russia.

This report addresses the critically important topics for analyzing a changing market dynamic, the emerging players and technologies, strategies for accessing these emerging markets, and specific disease segments and geographies in order to allow allocation of resources and make effective decisions.


No comments: